Hidehiko Fujii
Gifu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hidehiko Fujii.
European Journal of Immunology | 2001
Suwako Fujigaki; Kuniaki Saito; Kenji Sekikawa; Shigenobu Tone; Osamu Takikawa; Hidehiko Fujii; Hisayasu Wada; Akio Noma; Mitsuru Seishima
Indoleamine 2,3‐dioxygenase (IDO) is a rate‐limiting enzyme in the L‐tryptophan‐kynurenine pathway, which converts an essential amino acid, L‐tryptophan, to N‐formylkynurenine. It has been speculated that IFN‐γ is a dominant IDO inducer in vivo. The present study used IFN‐γ or TNF‐α gene‐disrupted mice and IFN‐γ antibody‐treated mice to demonstrate that lipopolysaccharide (LPS)‐induced systemic IDO is largely dependent on TNF‐α rather than IFN‐γ. IFN‐γ‐independent IDO induction was also demonstrated in vitro with LPS‐stimulated monocytic THP‐1 cells. These findings clearly indicate that there is an IFN‐γ‐independent mechanism of IDO induction in addition to the IFN‐γ‐dependent mechanism.
Circulation | 2001
Hisayasu Wada; Kuniaki Saito; Tsugiyasu Kanda; Isao Kobayashi; Hidehiko Fujii; Suwako Fujigaki; Naoya Maekawa; Hisato Takatsu; Hisayoshi Fujiwara; Kenji Sekikawa; Mitsuru Seishima
BACKGROUND It has been reported that tumor necrosis factor-alpha (TNF-alpha) is expressed in the heart with viral myocarditis and that its expression aggravates the condition. The pathophysiological effects of TNF-alpha on viral myocarditis, however, have not been fully elucidated. METHODS AND RESULTS To investigate the role of TNF-alpha in the progression of viral myocarditis, we used TNF-alpha gene-deficient mice (TNF-alpha(-/-)) and induced acute myocarditis by infection with encephalomyocarditis virus (EMCV). The survival rate of TNF-alpha(-/-) mice after EMCV infection was significantly lower than that of TNF-alpha(+/+) mice (0% versus 67% on day 14). Injection of recombinant human TNF-alpha (0.2 to 4.0 microg/mouse IV) improved the survival of TNF-alpha(-/-) mice in a dose-dependent manner, indicating that TNF-alpha is essential for protection against viral myocarditis. The levels of viral titer and viral genomic RNA of EMCV in the myocardium were significantly higher in TNF-alpha(-/-) than in TNF-alpha(+/+) mice. Histopathological examination showed that the inflammatory changes of the myocardium were less marked in TNF-alpha(-/-) than in TNF-alpha(+/+) mice. Immunohistochemical analysis revealed that the levels of immunoreactivity of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the myocardium were decreased in TNF-alpha(-/-) mice compared with TNF-alpha(+/+) mice. CONCLUSIONS These observations suggested that TNF-alpha is necessary for adhesion molecule expression and to recruit leukocytes to inflammatory sites, and thus, the lack of this cytokine resulted in failure of elimination of infectious agents. We concluded that TNF-alpha plays a protective role in the acute stage of viral myocarditis.Background—It has been reported that tumor necrosis factor-α (TNF-α) is expressed in the heart with viral myocarditis and that its expression aggravates the condition. The pathophysiological effects of TNF-α on viral myocarditis, however, have not been fully elucidated. Methods and Results—To investigate the role of TNF-α in the progression of viral myocarditis, we used TNF-α gene–deficient mice (TNF-α−/−) and induced acute myocarditis by infection with encephalomyocarditis virus (EMCV). The survival rate of TNF-α−/− mice after EMCV infection was significantly lower than that of TNF-α+/+ mice (0% versus 67% on day 14). Injection of recombinant human TNF-α (0.2 to 4.0 μg/mouse IV) improved the survival of TNF-α−/− mice in a dose-dependent manner, indicating that TNF-α is essential for protection against viral myocarditis. The levels of viral titer and viral genomic RNA of EMCV in the myocardium were significantly higher in TNF-α−/− than in TNF-α+/+ mice. Histopathological examination showed that the inflam...
Annals of Clinical Biochemistry | 2001
Toshiko Morita; Kuniaki Saito; Masao Takemura; Naoya Maekawa; Suwako Fujigaki; Hidehiko Fujii; Hisayasu Wada; Shoji Takeuchi; Akio Noma; Mitsuru Seishima
3-Hydroxyanthranilic acid (3-HAA), a metabolite of L-tryptophan, accumulates in monocyte-derived cells (THP-1),but not in other celllines tested(MRC9, H4, U373MG, Wil-NS), following immune stimulation that induces indoleamine 2,3-dioxygenase (IDO), a rate-limiting enzyme in the L-tryptophan-kynurenine pathway. We examined whether metabolites of the L-tryptophan-kynurenine pathway act to induce apoptosis in monocytes/macrophages. Of the L-tryptophan metabolites tested, only 3-HAA at a concentration of 200µmol/L was found to induce apoptosis in THP-1 and U937 cells. The addition of ferrous or manganese ions further enhanced apoptosis and free radical formation by 3-HAA in these two types of cells. The apoptotic response induced by 3-HAA was significantly attenuated by the addition of antioxidant, α-tocopherol or Trolox (a water-soluble analogue of vitamin E), and the xanthine oxidase inhibitor, allopurinol. In addition, the 3-HAA-induced apoptotic response was slightly attenuated by catalase, but not by superoxide dismutase (SOD), indicating that generation of hydrogen peroxide is involved in this response. Interferon-γ (IFN-γ), an inducer of IDO, potently induced apoptosis in THP-1 cells, but not in U937 cells, in the presence of ferrous or manganese ions. This different susceptibility to apoptosis inducer between THP-1 and U937 cells may depend on the capacity of the cells for 3-HAA synthesis following IDO induction by IFN-γ. Furthermore, apoptosis was suppressed by cycloheximide in THP-1 cells, suggesting that newly synthesized proteins may be essential for apoptotic events. These results suggest that 3-HAA induces apoptosis in monocytes/macrophages under inflammatory or other pathophysiological conditions.
Journal of Neurochemistry | 2005
Yuki Murakami; Kuniaki Saito; Akira Hara; Yuyan Zhu; Kaori Sudo; Masayuki Niwa; Hidehiko Fujii; Hisayasu Wada; Hiroshi Ishiguro; Hideki Mori; Mitsuru Seishima
The actions of tumor necrosis factor‐α (TNF‐α) produced by resident brain cells and bone marrow‐derived cells in brain following a transient global ischemia were evaluated. In wild‐type mice (C57Bl/6J) following 20 min ischemia with bilateral common carotid artery occlusion (BCCAo), TNF‐α mRNA expression levels in the hippocampus were significantly increased at 3 h and 36 h and exhibited a biphasic expression pattern. There were no hippocampal TNF‐α mRNA expression levels at early time points in either wild‐type mice bone marrow transplanted (BMT)‐chimeric‐TNF‐α gene‐deficient (T/W) or TNF‐α gene‐deficient mice BMT‐TNF‐α gene‐deficient mice (T/T), although TNF‐α mRNA levels were detectable in T/W BMT mice at 36 h. Histopathological findings showed no intergroup differences between wild‐type and TNF‐α gene‐deficient mice at 4 and 7 days after transient ischemia. In addition, nuclear factor‐κB (NF‐κB) was activated within 12 h after global cerebral ischemia, but electrophoretic mobility shift assays (EMSA) showed no intergroup differences between wild type and TNF‐α gene‐deficient mice. In summary, early hippocampal TNF‐α mRNA expression may not be related to bone marrow‐derived cells, and secondary TNF‐α expression as early as 36 h after ischemia probably resulted mainly from endogenous brain cells and possibly a few bone marrow‐derived cells. Although we cannot exclude the possibility of the TNF‐α contribution to the physiologic changes of hippocampus after transient global ischemia, these results indicate that TNF‐α does not influence the morphological changes of the hippocampal neurons under our study condition.
The FASEB Journal | 2000
Ryuichi Iida; Kuniaki Saito; Kiyofumi Yamada; Anthony S. Basile; Kenji Sekikawa; Masao Takemura; Hidehiko Fujii; Hisayasu Wada; Mitsuru Seishima; Toshitaka Nabeshima
Brain levels of TNF‐α increase in many inflammatory conditions, including HIV‐1 infection, and may contribute to neurodegenerative processes. The paucity of agents that can selectively and potently block TNF‐α processing or its receptors has led us to investigate the role of TNF‐α in chronic neurodegeneration associated with retroviral infection using mice with targeted deletions of the TNF‐α gene. Infection of wild‐type C57BL/6 mice with the LP‐BM5 murine leukemia retrovirus mixture leads to the development of a severe immunodeficiency as well as cognitive deficits and neuronal damage. TNF‐α‐(‐/‐) mice infected with LP‐BM5 developed a systemic immunopathology indistinguishable in severity from that observed in contemporaneously infected wild‐type mice. In contrast, the performance of infected TNF‐α‐(‐/‐) mice in the γ‐maze and Morris water maze was not different from that of uninfected TNF‐α‐(‐/‐) mice. The extent of glial activation in the striatum, as indicated by the increase in density of peripheral benzodiazepine receptors, was equivalent in both groups of LP‐BM5‐infected mice. However, the decrease in striatal MAP‐2 expression, a marker of neurodegeneration observed in infected wild‐type mice, was not found in infected TNF‐α‐(‐/‐) mice. While the loss of TNF‐α appeared to have no effect on the course or severity of the central or peripheral immunopathology resulting from LP‐BM5 infection, the behavioral and biochemical manifestations were substantially curtailed in the TNF‐α‐(‐/‐) mice. These findings directly support a role for TNF‐α in the neurodegenerative processes associated with viral infections such as HIV‐1.—Iida, R., Saito, K., Yamada, K., Basile, A. S., Sekikawa, K., Takemura, M., Fujii, Wada, H. H., Seishima, M., Nabeshima, T. Suppression of neurocognitive damage in LP‐BM5‐infected mice with a targeted deletion of the TNF‐α gene. FASEBJ. 14, 1023–1031 (2000)
Advances in Experimental Medicine and Biology | 1999
Toshiko Morita; Kuniaki Saito; Masao Takemura; Naoya Maekawa; Suwako Fujigaki; Hidehiko Fujii; Hisayasu Wada; Shoji Takeuchi; Akio Noma; Mitsuru Seishima
Accumulation of L-kynurenine and 3-hydroxyanthranilic acid (3HAA) occurs in the monocyte-derived cells following immune stimulation, and may derive from L-tryptophan following induction of indoleamine-2,3-dioxygenase. In the present study, we evaluate the possibility that 3HAA acts as an endogenous inducer of monocyte/macrophage apoptosis. Supplementation with 200 microM of 3HAA, but not other L-tryptophan metabolites tested, significantly increased the number of apoptotic cells in both THP-1 and U937 cells. Catalase, superoxide dismutase and manganese ions markedly enhanced apoptosis in the presence of 3HAA in these cells. The present results suggest that 3HAA induces the macrophage/monocyte apoptosis under certain conditions, which may be relevant to pathophysiology of inflammatory conditions.
Annals of Allergy Asthma & Immunology | 2000
Hidehiko Fujii; Osamu Fukutomi; Ryosuke Inoue; Shinji Shinoda; Hiroyuki Okammoto; Takahide Teramoto; Naomi Kondo; Hisayasu Wada; Kuniaki Saito; Toshio Matsuoka; Mitsuru Seishima
BACKGROUND Bronchial asthma is associated with abnormal autonomic nervous function in childhood. Exercise is one of the most common precipitating factors of acute asthmatic crises although the exact mechanism of autonomic regulation in asthmatic children after exercise is unclear. OBJECTIVE The aim of this study was to investigate the features of autonomic regulation after exercise in asthmatic and control children. METHODS Pulmonary function tests and heart rate variability spectral analysis were performed in 15 asthmatic children and 7 control children (age 6 to 15 years) during and after an exercise challenge. RESULTS The maximum % fall of forced expiratory volume in 1 second (FEV1) was significantly greater (P < .01) in asthmatic subjects (9.1 +/- 5.1%) than in normal control subjects (1.0 +/- 2.5%). The high frequency band (HF) amplitude, an index of cardiac vagal tone, 5 minutes after exercise was significantly higher (P < .05) in the asthmatic subjects (14.4 +/- 7.9 msec) than in control subjects (5.9 +/- 2.6 msec). Furthermore, the difference in the HF amplitude between the control group and the exercise-induced asthma group was significant both 5 minutes (P < .01) and 10 minutes (P < .05) after challenge. There was a significant correlation (P = .565, P = .0165) between HF amplitude 5 minutes after exercise and the magnitude of the decrease in FEV1. On the other hand, no significant difference was observed in the low frequency band amplitude between the controls and the asthmatic subjects. The ratio of low frequency to high frequency power, which is suggested to correlate with cardiac sympathetic activity, did not differ between the two groups. CONCLUSION These findings suggest that autonomic nervous activities, particularly vagal response after exercise, in asthmatic children is different from that in control children.
European Journal of Immunogenetics | 1995
Naoki Kuwabara; Naomi Kondo; Osamu Fukutomi; Hidehiko Fujii; Tadao Orii
Human IgE synthesis requires the presence of both interleukin 4 (IL‐4) and T‐cells. However, it is not clear what role IL‐4 and T‐cells play in the induction of IgE synthesis at the level of gene regulation. B cells that were obtained from patients with a high level of serum IgE and from healthy donors were immortalized by Epstein‐Barr virus. We examined IgE production of these B cells stimulated with IL‐4. Supernatant IgE levels of patients B cells cultured with or without IL‐4 were higher than those of healthy donors B cells. Our results indicated that B cells stimulated with IL‐4 from patients produced IgE, germline C ε transcript, and S μ S ε recombination. The germline C e transcript was dose‐dependently induced in the presence of IL‐4 and related to the supernatant IgE level. In B cells stimulated with IL‐4 that were obtained from patients, (some of the) DNA near or within the I e region was (already partly) unmethylated, unlike those from healthy donors, and there was a loss of methyl groups of the DNA upon the addition of IL‐4 in B cells from both patients and normal donors. IgE synthesis of B cells stimulated with IL‐4 in patients with a high level of serum IgE is due to an accessibility in the immunoglobulin heavy‐chain isotype switch, and this may reflect the accessibility in synthesis of germline C ε transcript, which may be caused by the increase of opening chromatin structures because of their unmethylation in the I ε region.
Annals of Clinical Biochemistry | 2004
Hidetsugu Fujigaki; Masao Takemura; Kanako Takahashi; Yasuhiro Yamada; Hidehiko Fujii; Hisayasu Wada; Kuniaki Saito; Hiroo Ohnishi; Mitsuru Seishima
Background: Recent studies have focused on whether different hepatitis C virus (HCV) genotypes are associated with different profiles of pathogenicity, infectivity, and response to antiviral therapy. We needed to develop a convenient screening test for HCV genotypes 1 and 2. Method: We tested 55 patients with known chronic HCV infection. Viral RNA was extracted from serum samples using an automatic viral RNA purification system, and HCV genotypes were determined by reverse transcriptase-polymerase chain reaction using LightCycler melting curve analysis with SYBR Green I. Results: HCV RNA was detected in all samples and each genotype was determined. The mean (standard deviation) melting temperatures for subtypes 1b (n = 32), 2a (n = 15) and 2b (n = 8) were 93.14°C (0.51°C), 91.08°C (0.49°C) and 91.77°C (0.27°C), respectively. Genotypes 1 and 2 were differentiated within 3 h by this method. Conclusions: Our melting curve analysis is a rapid and convenient screening test for differential identification of HCV genotypes 1 and 2.
International Archives of Allergy and Immunology | 1995
Hidehiko Fujii; Naomi Kondo; Hiroatsu Agata; Osamu Fukutomi; Shinji Shinoda; Naoki Kuwabara; Shunji Tomatsu; Tomio Kondo; Ryosuke Inoue; Tadao Orii
The familial occurrence of allergic diseases was studied in 478 individuals and their family members. The results showed that there was pronounced familial clustering. Total serum IgE concentrations of atopic patients and their parents were well correlated. Moreover, the concentration of specific IgE of the patients and their parents was also well correlated, suggesting that IgE production was genetically determined. To determine if major structural abnormalities of IGHE, IGHEP1 and IGHEP2 genes might lead to aberrant control and subsequent increase in IgE concentration, genomic DNAs from 55 individuals, i.e., 31 atopic patients and their family members, were examined. We detected the IGHE, IGHEP1 and IGHEP2 genes in all 55 leukocyte DNAs. We could not find any large deletions or duplications in the IGHE, IGHEP1 and IGHEP2 genes of atopic patients with high serum IgE concentrations.